Downregulation of EIF5A2 by miR-221-3p inhibits cell proliferation, promotes cell cycle arrest and apoptosis in medulloblastoma cells

References

• Northcott PA, Lee C, Zichner T, et al. Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma. Nature. 2014 Jul 24;511(7510):428–434. PubMed PMID: 25043047; PubMed Central PMCID: PMCPMC4201514.
   PubMed Web of Science ®Google Scholar
• Srinivasan VM, Ghali MG, North RY, et al. Modern management of medulloblastoma: molecular classification, outcomes, and the role of surgery. Surg Neurol Int. 2016;7(Suppl 44):S1135–S1141. PubMed PMID: 28194300; PubMed Central PMCID: PMCPMC5299153.
   PubMedGoogle Scholar
• Wang J, Garancher A, Ramaswamy V, et al. Medulloblastoma: from molecular subgroups to molecular targeted therapies. Annu Rev Neurosci. 2018 Apr 11;41:207–232. PubMed PMID: 29641939.
   Web of Science ®Google Scholar
• Northcott PA, Korshunov A, Witt H, et al. Medulloblastoma comprises four distinct molecular variants. J Clin Oncol. 2011 Apr 10;29(11):1408–1414. PubMed PMID: 20823417; PubMed Central PMCID: PMCPMC4874239.
   PubMed Web of Science ®Google Scholar
• Kool M, Korshunov A, Remke M, et al. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, group 3, and group 4 medulloblastomas. Acta Neuropathol. 2012 Apr;123(4):473–484. PubMed PMID: 22358457; PubMed Central PMCID: PMCPMC3306778.
   PubMed Web of Science ®Google Scholar
• Bandara KV, Michael MZ, Gleadle JM. MicroRNA Biogenesis in Hypoxia. Microrna. 2017;6(2):80–96. PubMed PMID: 28294076.
   PubMedGoogle Scholar
• Jonas S, Izaurralde E. Towards a molecular understanding of microRNA-mediated gene silencing. Nat Rev Genet. 2015 Jul;16(7):421–433. PubMed PMID: 26077373.
   PubMed Web of Science ®Google Scholar
• Cohen JL, Ata AE, Jackson NL, et al. Differential stress induced c-Fos expression and identification of region-specific miRNA-mRNA networks in the dorsal raphe and amygdala of high-responder/low-responder rats. Behav Brain Res. 2017 Feb 15;319:110–123. PubMed PMID: 27865919; PubMed Central PMCID: PMCPMC5183530.
   PubMed Web of Science ®Google Scholar
• Xu G, Shao G, Pan Q, et al. MicroRNA-9 regulates non-small cell lung cancer cell invasion and migration by targeting eukaryotic translation initiation factor 5A2. Am J Transl Res. 2017;9(2):478–488. PubMed PMID: 28337276; PubMed Central PMCID: PMCPMC5340683.
   PubMed Web of Science ®Google Scholar
• Deng L, Lei Q, Wang Y, et al. Downregulation of miR-221-3p and upregulation of its target gene PARP1 are prognostic biomarkers for triple negative breast cancer patients and associated with poor prognosis. Oncotarget. 2017 Dec 12;8(65):108712–108725. PubMed PMID: 29312562; PubMed Central PMCID: PMC5752475.
   PubMedGoogle Scholar
• Wu Q, Ren X, Zhang Y, et al. MiR-221-3p targets ARF4 and inhibits the proliferation and migration of epithelial ovarian cancer cells. Biochem Biophys Res Commun. 2018 Mar 18;497(4):1162–1170. PubMed PMID: 28057486.
   PubMed Web of Science ®Google Scholar
• Wei WF, Zhou CF, Wu XG, et al. MicroRNA-221-3p, a TWIST2 target, promotes cervical cancer metastasis by directly targeting THBS2. Cell Death Dis. 2017 Dec 14;8(12):3220. 10.1038/s41419-017-0077-5. PubMed PMID: 29242498; PubMed Central PMCID: PMCPMC5870596.
   PubMed Web of Science ®Google Scholar
• Shi J, Zhang Y, Jin N, et al. MicroRNA-221-3p plays an oncogenic role in gastric carcinoma by inhibiting PTEN expression. Oncol Res. 2017 Apr 14;25(4):523–536. PubMed PMID: 27712596.
   PubMed Web of Science ®Google Scholar
• Li F, Xu JW, Wang L, et al. MicroRNA-221-3p is up-regulated and serves as a potential biomarker in pancreatic cancer. Artif Cells Nanomed Biotechnol. 2018 May;46(3):482–487. PubMed PMID: 28434388.
   PubMed Web of Science ®Google Scholar
• Tantawy M, Elzayat MG, Yehia D, et al. Identification of microRNA signature in different pediatric brain tumors. Genet Mol Biol. 2018 Jan–Mar;41(1):27–34. PubMed PMID: 29658967; PubMed Central PMCID: PMCPMC5901491.
   PubMed Web of Science ®Google Scholar
• Park MH. The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A). J Biochem. 2006 Feb;139(2):161–169. PubMed PMID: 16452303; PubMed Central PMCID: PMCPMC2494880.
   PubMed Web of Science ®Google Scholar
• Taylor CA, Zheng Q, Liu Z, et al. Role of p38 and JNK MAPK signaling pathways and tumor suppressor p53 on induction of apoptosis in response to Ad-eIF5A1 in A549 lung cancer cells. Mol Cancer. 2013 May 2;12:35. PubMed PMID: 23638878; PubMed Central PMCID: PMCPMC3660295.
   PubMed Web of Science ®Google Scholar
• Bussard KM, Mutkus L, Stumpf K, et al. Tumor-associated stromal cells as key contributors to the tumor microenvironment [journal article]. Breast Cancer Res. 2016 August 11;18(1):84.
   PubMed Web of Science ®Google Scholar
• Guan XY, Fung JM, Ma NF, et al. Oncogenic role of eIF-5A2 in the development of ovarian cancer. Cancer Res. 2004 Jun 15;64(12):4197–4200. PubMed PMID: 15205331.
   PubMed Web of Science ®Google Scholar
• Wei JH, Cao JZ, Zhang D, et al. EIF5A2 predicts outcome in localised invasive bladder cancer and promotes bladder cancer cell aggressiveness in vitro and in vivo. Br J Cancer. 2014 Apr 2;110(7):1767–1777. PubMed PMID: 24504366; PubMed Central PMCID: PMCPMC3974079.
   PubMed Web of Science ®Google Scholar
• Bao Y, Lu Y, Wang X, et al. Eukaryotic translation initiation factor 5A2 (eIF5A2) regulates chemoresistance in colorectal cancer through epithelial mesenchymal transition. Cancer Cell Int. 2015;15:109. PubMed PMID: 26581310; PubMed Central PMCID: PMCPMC4650515.
   PubMed Web of Science ®Google Scholar
• Eckerdt F, Beauchamp E, Bell J, et al. Regulatory effects of a Mnk2-eIF4E feedback loop during mTORC1 targeting of human medulloblastoma cells. Oncotarget. 2014 Sep 30;5(18):8442–8451. PubMed PMID: 25193863; PubMed Central PMCID: PMCPMC4226695.
   PubMedGoogle Scholar
• Brummer A, Hausser J. MicroRNA binding sites in the coding region of mRNAs: extending the repertoire of post-transcriptional gene regulation. Bioessays. 2014 Jun;36(6):617–626. PubMed PMID: 24737341.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Maruyama R, Yamamoto E, et al. Epigenetic alteration and microRNA dysregulation in cancer. Front Genet. 2013 Dec 3;4:258. PubMed PMID: 24348513; PubMed Central PMCID: PMCPMC3847369.
   PubMedGoogle Scholar
• Zakraoui O, Marcinkiewicz C, Aloui Z, et al. Lebein, a snake venom disintegrin, suppresses human colon cancer cells proliferation and tumor-induced angiogenesis through cell cycle arrest, apoptosis induction and inhibition of VEGF expression. Mol Carcinog. 2017 Jan;56(1):18–35. PubMed PMID: 26824338.
   PubMed Web of Science ®Google Scholar
• Asghar U, Witkiewicz AK, Turner NC, et al. The history and future of targeting cyclin-dependent kinases in cancer therapy. Nat Rev Drug Discov. 2015 Feb;14(2):130–146. PubMed PMID: 25633797; PubMed Central PMCID: PMCPMC4480421.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Vera JA, Bouzada D, Bouclier C, et al. Lanthanide-based peptide biosensor to monitor CDK4/cyclin D kinase activity. Chem Commun (Camb). 2017 Jun 1;53(45):6109–6112. PubMed PMID: 28530267.
   PubMed Web of Science ®Google Scholar
• Whittaker SR, Barlow C, Martin MP, et al. Molecular profiling and combinatorial activity of CCT068127: a potent CDK2 and CDK9 inhibitor. Mol Oncol. 2018 Mar;12(3):287–304. PubMed PMID: 29063678; PubMed Central PMCID: PMCPMC5830651.
   PubMed Web of Science ®Google Scholar
• Opferman JT, Kothari A. Anti-apoptotic BCL-2 family members in development. Cell Death Differ. 2018 Jan;25(1):37–45. PubMed PMID: 29099482; PubMed Central PMCID: PMCPMC5729530.
   PubMed Web of Science ®Google Scholar
• Siddiqui WA, Ahad A, Ahsan H. The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update. Arch Toxicol. 2015 Mar;89(3):289–317. PubMed PMID: 25618543.
   PubMed Web of Science ®Google Scholar
• Reed JC, Stein C, Subasinghe C, et al. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides. Cancer Res. 1990 Oct 15;50(20):6565–6570. PubMed PMID: 2208117.
   PubMed Web of Science ®Google Scholar
• Sun SY, Yue P, Zhou JY, et al. Overexpression of BCL2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells. Biochem Biophys Res Commun. 2001 Jan 26;280(3):788–797. PubMed PMID: 11162590.
   PubMed Web of Science ®Google Scholar
• Lin YC, Lin JF, Tsai TF, et al. Tumor suppressor miRNA-204-5p promotes apoptosis by targeting BCL2 in prostate cancer cells. Asian J Surg. 2017 Sep;40(5):396–406. PubMed PMID: 27519795.
   PubMed Web of Science ®Google Scholar
• Zhu W, Cai MY, Tong ZT, et al. Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransition. Gut. 2012 Apr;61(4):562–575. PubMed PMID: 21813470.
   PubMed Web of Science ®Google Scholar
• Meng QB, Kang WM, Yu JC, et al. Overexpression of eukaryotic translation initiation factor 5A2 (EIF5A2) correlates with cell aggressiveness and poor survival in gastric cancer. PloS one. 2015;10(3):e0119229. PubMed PMID: 25793713; PubMed Central PMCID: PMC4368542.
   PubMed Web of Science ®Google Scholar